ENTITY
Ionis Pharmaceuticals

Ionis Pharmaceuticals (IONS US)

54
Analysis
Health CareUnited States
Ionis Pharmaceuticals, Inc. operates as a biotechnology company. The Company researches in RNA-targeted drug discovery and development that focuses on drugs for patients who have unmet medical needs. Ionis Pharmaceuticals serves customers in the United States.
more
17 Nov 2024 09:29

Who Are Leading the Charge in the RNAissance of Medicine

RNA therapeutics: We analyze the field and spotlight top players driving this precision medicine, for tackling rare diseases with innovative solutions

Logo
103 Views
Share
14 Aug 2024 19:00

Ionis Pharmaceuticals: These Are The Key Advancements in Angelman Syndrome and Broad Neurology Portfolio! - Major Drivers

Ionis Pharmaceuticals Inc., a leader in RNA-targeted therapeutics, recently held its second quarter 2024 earnings call outlining several...

Logo
110 Views
Share
02 Jul 2024 15:00

Ionis Pharmaceuticals Inc.: Expanding Pipeline with Promising Drug Candidates! - Major Growth Drivers

Ionis Pharmaceuticals commenced the year 2024 with notable strides, particularly through the launch of WAINUA in the U.S. This product, among...

Logo
217 Views
Share
06 Apr 2024 18:00

Ionis Pharmaceuticals Inc.: Initiation Of Coverage - Its New wholly-owned medicines and Independent launches Can Catalyze Growth? - Major Drivers

Ionis Pharmaceuticals Inc. had a remarkable year in 2023, with significant advancements in their RNA targeting platform and a steady stream of...

Logo
303 Views
Share
04 Sep 2024 19:50Issuer-paid

Biopharma Week in Review - September 3, 2024

Last week, ALNY’s detailed ATTR cardiomyopathy data left room for competitors, with BBIO benefiting and an opening for IONS.

Logo
71 Views
Share
x